Letters

Patient's sex does not affect use of thrombolysis

BMJ 1998; 316 doi: https://doi.org/10.1136/bmj.316.7128.391 (Published 31 January 1998) Cite this as: BMJ 1998;316:391
  1. Rosalind Raine, MRC/North Thames clinical research fellowa,
  2. Tim Crayford, Senior clinical fellowb,
  3. John Chambers, Senior lecturerc
  1. a Health Services Research Unit, London School of Hygiene and Tropical Medicine, London WC1E 7HT
  2. b Department of Public Health and Epidemiology, King's College School of Medicine and Dentistry, London SE5 9PJ
  3. c Department of Cardiology, Guy's Hospital, London SE1 9RT

    Editor—Wenger's review of the importance of coronary heart disease in American women is equally applicable to women in Britain.1 Wenger points out that the prognosis is influenced by access to clinical interventions, and she suggests that underuse of thrombolysis in women may have a cascade effect on risk stratification.

    Her assertion that patients who have had thrombolytic treatment seem more likely to undergo investigation is unreferenced. In addition, the study quoted as showing lower use of thrombolysis …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe